TransMESO
Research type
Research Study
Full title
Translational study of samples from patients with MESOthelioma (TransMESO)
IRAS ID
323168
Contact name
Dean Fennell
Contact email
Sponsor organisation
University of Southampton
Duration of Study in the UK
10 years, 0 months, 0 days
Research summary
The TransMESO study aims to further extend our understanding of mesothelioma and to identify new biomarkers, or clues, that can identify people with mesothelioma. This will be done by investigating samples from mesothelioma patients collected in the CONFIRM clinical trial or other ethically approved mesothelioma trials managed by the Southampton Clinical Trials Unit.
REC name
North East - York Research Ethics Committee
REC reference
23/NE/0052
Date of REC Opinion
17 Mar 2023
REC opinion
Further Information Favourable Opinion